Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia

BACKGROUND: Very few studies have compared the effects and side effects of vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia. This study aimed to compare the efficacy and safety of vancomycin and teicoplanin in patients with methicillin-resistant Staph...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jang Ho, Choi, Myeong Geun, Park, Hyung Jun, Kim, Ho Cheol, Choi, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264637/
https://www.ncbi.nlm.nih.gov/pubmed/35799129
http://dx.doi.org/10.1186/s12879-022-07549-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264637/
https://www.ncbi.nlm.nih.gov/pubmed/35799129
http://dx.doi.org/10.1186/s12879-022-07549-2

Ejemplares similares